Safe, Effective, and
FDA-approved Biosimilars

Biosimilar medicines are increasing patient access to care and reducing drug costs…

But what are biosimilars?

Whether you are a patient, caregiver, medical professional, insurer or policy maker, this handbook is designed to give you a crash course on the basics of biosimilars.

Learning Tracks

Each of our four expert-developed learning tracks will give you a deeper understanding of biosimilars so you can make more informed decisions.

Select a learning track below to learn more.

I’m a Patient or Caregiver

I’m a Medical Professional

I’m a Payer

I’m a Policy Maker

View up-to-date list of FDA-approved biosimilars

Biosimilars Council Blog

Pink Ribbon Breast Cancer Girls Feminine Copy Space Banner Concept

October 25, 2022

2022 Savings Report Shows the Value of Biosimilars for Patients with Cancer

Each year, more biosimilars continue to reach new patients, delivering greater savings to them, taxpayers, and the…

Young male pharmacist giving prescription medications to senior female customer in a pharmacy with female pharmacist in the background

October 9, 2021

Pharmacists Can Help Spur Greater Biosimilar Adoption

As trusted partners for patients, pharmacists have a critical role to play in educating consumers about biosimilar medicines…

Biosimilars Reach More Patients in 2022, Yet Challenges Remain

October 6, 2021

Biosimilars Reach More Patients in 2022, Yet Challenges Remain

Although biosimilars have made great strides in the last year, there remains much work to be done. This…